CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer
Author(s)
Date
2021-04Source Title
Cellular Oncology
Electronic ISSN
1875-8606
Publisher
Springer
Volume
44
Pages
453 - 472
Language
English
Type
ArticleItem Usage Stats
47
views
views
151
downloads
downloads
Abstract
Cholinergic signals can be important modulators of cellular signaling in cancer. We recently have shown that knockdown of nicotinic acetylcholine receptor subunit alpha 5, CHRNA5, diminishes the proliferative potential of breast cancer cells. However, modulation of CHRNA5 expression in the context of estrogen signaling and its prognostic implications in breast cancer remained unexplored.
Keywords
Breast cancerCHRNA5
Meta-analysis
Co-expression network
Estrogen receptor targets
Estrogen treatment
Prognosis